VIVS
VivoSim Labs, INC.
Key Financials
Operating Income
$-11487000
↑ 8.9%
Revenue
$131000
↓ 9.0%
Net Income
$-13843000
↓ 456.4%
EPS (Diluted)
$-5.35
↓ 214.7%
Total Liabilities
$8.5M
↑ 104.1%
Total Assets
$7.4M
↓ 49.6%
Shareholders' Equity
$-1099000.00
↓ 110.5%
Cash & Equivalents
$5.0M
↓ 55.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/17/2026 | View on SEC |
| PRER14A | 8/13/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| EFFECT | 8/10/2026 | View on SEC |
| PRE 14A | 8/10/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| S-1 | 7/31/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| 8-K | 7/24/2026 | View on SEC |
| 8-K | 7/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VIVS |
| Company Name | VivoSim Labs, INC. |
| CIK | 1497253 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | 858-224-1000 |